Literature DB >> 21235583

The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin.

Zhen Yu1, Woon-Gye Chung, Brian R Sloat, Christiane V Löhr, Richard Weiss, B Leticia Rodriguez, Xinran Li, Zhengrong Cui.   

Abstract

OBJECTIVES: Non-invasive immunization by application of plasmid DNA topically onto the skin is an attractive immunization approach. However, the immune responses induced are generally weak. Previously, we showed that the antibody responses induced by topical DNA vaccine are significantly enhanced when hair follicles in the application area are induced into the anagen (growth) stage by hair plucking. In the present study, we further investigated the mechanism of immune enhancement.
METHODS: Three different methods--hair plucking or treatment with retinoic acid (RA) or O-tetradecanoylphorbol-13-acetate (TPA)--were used to induce mice hair follicles into the anagen stage before they were dosed with a β-galactosidase-encoding plasmid, and the specific antibody responses induced were evaluated. KEY
FINDINGS: The hair-plucking method was more effective at enhancing the resultant antibody responses. Treatment with RA or TPA caused more damage to the skin and induced more severe local inflammation than hair plucking. However, hair plucking was most effective at enhancing the uptake or retention of the DNA in the application area.
CONCLUSIONS: The uptake of plasmid DNA in the application area correlated with the antibody responses induced by a topically applied DNA.
© 2011 The Authors. JPP © 2011 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235583      PMCID: PMC3148656          DOI: 10.1111/j.2042-7158.2010.01219.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  34 in total

1.  Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.

Authors:  Wolfgang W Leitner; Leroy N Hwang; Elke S Bergmann-Leitner; Steven E Finkelstein; Stephan Frank; Nicholas P Restifo
Journal:  Vaccine       Date:  2004-03-29       Impact factor: 3.641

2.  Enhancement of tumor-specific immune response with plasmid DNA replicon vectors.

Authors:  W W Leitner; H Ying; D A Driver; T W Dubensky; N P Restifo
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

3.  Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.

Authors:  Brian R Sloat; Zhengrong Cui
Journal:  Vaccine       Date:  2006-06-19       Impact factor: 3.641

4.  Topical immunization using nanoengineered genetic vaccines.

Authors:  Zhengrong Cui; Russell J Mumper
Journal:  J Control Release       Date:  2002-05-17       Impact factor: 9.776

5.  Sebum output as a factor contributing to the size of facial pores.

Authors:  M Roh; M Han; D Kim; K Chung
Journal:  Br J Dermatol       Date:  2006-11       Impact factor: 9.302

6.  Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy.

Authors:  Uyen M Le; Zhengrong Cui
Journal:  Int J Pharm       Date:  2006-05-19       Impact factor: 5.875

7.  Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice.

Authors:  Brice Mahe; Annika Vogt; Christelle Liard; Darragh Duffy; Valérie Abadie; Olivia Bonduelle; Alexandre Boissonnas; Wolfram Sterry; Bernard Verrier; Ulrike Blume-Peytavi; Behazine Combadiere
Journal:  J Invest Dermatol       Date:  2008-12-04       Impact factor: 8.551

8.  The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses.

Authors:  Zhengrong Cui; Russell J Mumper
Journal:  Eur J Pharm Biopharm       Date:  2003-01       Impact factor: 5.571

9.  Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum.

Authors:  Gregory M Glenn; Christina P Villar; David C Flyer; A Louis Bourgeois; Robin McKenzie; Robert M Lavker; Sarah A Frech
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

10.  Induction of protective immunity against lethal anthrax challenge with a patch.

Authors:  Richard T Kenney; Jianmei Yu; Mimi Guebre-Xabier; Sarah A Frech; Adam Lambert; Barbara A Heller; Larry R Ellingsworth; James E Eyles; E Diane Williamson; Gregory M Glenn
Journal:  J Infect Dis       Date:  2004-07-13       Impact factor: 5.226

View more
  4 in total

1.  Stem cell plasticity enables hair regeneration following Lgr5+ cell loss.

Authors:  Joerg D Hoeck; Brian Biehs; Antonina V Kurtova; Noelyn M Kljavin; Felipe de Sousa E Melo; Bruno Alicke; Hartmut Koeppen; Zora Modrusan; Robert Piskol; Frederic J de Sauvage
Journal:  Nat Cell Biol       Date:  2017-05-29       Impact factor: 28.824

2.  Transcutaneous DNA immunization following waxing-based hair depilation.

Authors:  Brian R Sloat; Kaoru Kiguchi; Gang Xiao; John DiGiovanni; Wendy Maury; Zhengrong Cui
Journal:  J Control Release       Date:  2011-09-01       Impact factor: 9.776

Review 3.  Nanoparticles for transcutaneous vaccination.

Authors:  Steffi Hansen; Claus-Michael Lehr
Journal:  Microb Biotechnol       Date:  2011-08-19       Impact factor: 5.813

4.  Dynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunization.

Authors:  Teerawan Rattanapak; James C Birchall; Katherine Young; Atsuko Kubo; Sayumi Fujimori; Masaru Ishii; Sarah Hook
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.